Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chelation therapy.

P C Carven, H F Morrelli

    The Western Journal of Medicine
    |March 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Chelation therapy using ethylene tetraacetic acid (EDTA) was evaluated for treating atherosclerotic cardiovascular disease. The review assessed potential benefits against known toxicities of this EDTA chelation treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hoarseness due to mitral valve prolapse.

    Journal of the American Geriatrics Society·1988
    Same author

    Neuromuscular blockade due to gentamicin sulfate.

    The Western journal of medicine·1988
    Same author

    Factitious hyperamylasuria: a trap in the diagnosis of pancreatitis.

    The New England journal of medicine·1982
    Same author

    Systemic alkalosis and digitalis related arrhythmias.

    Acta medica Scandinavica. Supplementum·1981
    Same author

    Digoxin toxicity in patients with normokalemic potassium depletion.

    Clinical pharmacology and therapeutics·1977
    Same author

    Cardiovascular drug interactions.

    Annual review of pharmacology and toxicology·1977
    Same journal

    Does daily use of sunscreen or beta-carotene supplements prevent skin cancer in healthy adults?

    The Western journal of medicine·2008
    Same journal

    [Not Available].

    The Western journal of medicine·2008
    Same journal

    [Not Available].

    The Western journal of medicine·2008
    Same journal

    [Not Available].

    The Western journal of medicine·2008
    Same journal

    [Not Available].

    The Western journal of medicine·2008
    Same journal

    [Not Available].

    The Western journal of medicine·2008
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Toxicology

    Background:

    • Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of mortality worldwide.
    • Chelation therapy, particularly using ethylene tetraacetic acid (EDTA), has been proposed as a treatment for ASCVD.
    • Clinical Pharmacology services are often consulted to evaluate novel or controversial therapeutic approaches.

    Purpose of the Study:

    • To evaluate the potential therapeutic efficacy of chelation therapy with EDTA for atherosclerotic cardiovascular disease.
    • To assess the possible toxicities and adverse effects associated with EDTA chelation therapy.
    • To provide a clinical pharmacology perspective on the use of EDTA in ASCVD.

    Main Methods:

    • Literature review and analysis of existing studies on EDTA chelation therapy.

    Related Experiment Videos

  • Evaluation of pharmacological mechanisms of EDTA.
  • Assessment of reported clinical outcomes and toxicity data in patients with ASCVD.

    • Main Results:

    • Evidence supporting the therapeutic use of EDTA chelation for ASCVD is limited and controversial.
    • Potential toxicities of EDTA chelation therapy include nephrotoxicity and electrolyte imbalances.
    • The mechanism by which EDTA might benefit ASCVD is not well-established.

    Conclusions:

    • The use of EDTA chelation therapy for atherosclerotic cardiovascular disease is not supported by robust scientific evidence.
    • The potential risks and toxicities associated with EDTA chelation therapy must be carefully considered.
    • Further rigorous clinical trials are needed to definitively establish the safety and efficacy of EDTA chelation therapy.